Chargement en cours...
EGFR/HER-targeted therapeutics in ovarian cancer
Despite decades of research and evolving treatment modalities, survival among patients with epithelial ovarian cancer has improved only incrementally. During this same period, the development of biologically targeted therapeutics has improved survival for patients with diverse malignancies. Many of...
Enregistré dans:
| Publié dans: | Future Med Chem |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4620931/ https://ncbi.nlm.nih.gov/pubmed/22416774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc.12.11 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|